Loading...
Please wait, while we are loading the content...
Similar Documents
Gender differences in left ventricular hypertrophy regression.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Escobar, C. Julio Cesar Barrios, Vivencio |
| Copyright Year | 2008 |
| Abstract | To the Editor: We read with interest the article of Os et al1 about the effects of losartan in women with hypertension and left ventricular hypertrophy from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study. The main finding in this posthoc analysis was that, compared with atenolol-based treatment, losartan-based therapy resulted in fewer overall cardiovascular events and strokes, reduced total mortality, and less new-onset diabetes in women with hypertension and left ventricular hypertrophy (LVH). Overall, fewer events occurred in women than in men. A gender difference in the primary … |
| Starting Page | 955 |
| Ending Page | 961 |
| Page Count | 7 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://hyper.ahajournals.org/content/hypertensionaha/51/6/e58.full.pdf?download=true |
| PubMed reference number | 18443235v1 |
| Alternate Webpage(s) | https://doi.org/10.1161/HYPERTENSIONAHA.108.113225 |
| DOI | 10.1161/hypertensionaha.108.113225 |
| Journal | Hypertension |
| Volume Number | 51 |
| Issue Number | 6 |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Antihypertensive Agents Atenolol BaseLine dental cement Cerebrovascular accident Diabetes Mellitus Echocardiography Heart Ventricle Hypertensive disease Left Ventricular Hypertrophy Lichen Sclerosus et Atrophicus Losartan Morbidity - disease rate Sex Characteristics candesartan |
| Content Type | Text |
| Resource Type | Article |
